
Vibolop 0.1% Eye Drop
Marketer
Vibcare Pharma Pvt Ltd
Salt Composition
Olopatadine (0.1% w/v)
Overview Vibolop 0.1% Eye Drop
Allergic conjunctivitis, characterized by eye irritation, redness, itching, and swelling, responds to treatment with Vibolop 0.1% eye drops, an antihistamine. This medication effectively addresses symptoms triggered by allergens such as pollen, dust, and pet dander. Adhere strictly to your physician's prescribed dosage and frequency for optimal results. Consistent use, completing the entire course as directed, is crucial, even if symptom relief is experienced early. While some users may experience temporary burning, stinging, or irritation, these side effects are generally short-lived.
Uses of Vibolop 0.1% Eye Drop
Managing Allergic Responses
Major Benefits of Vibolop 0.1% Eye Drop:
Apply this medication topically only. Administer as prescribed by your physician, following the dosage and timeframe instructions. Consult the product label for application guidance prior to use. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.
Common Side effects of Vibolop 0.1% Eye Drop:
- Eye pain
- Eye irritation
- Abnormal eye sensation
- Eye discomfort
- Sleepiness
- Weakness
- Dryness in mouth
How to use Vibolop 0.1% Eye Drop:
Apply this medication externally only. Administer as directed by your physician, following the prescribed dosage and treatment schedule. Always consult the product label for application instructions. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.
How Vibolop 0.1% Eye Drop works:
Allergy relief is provided by Vibolop 0.1% ophthalmic solution, an antihistamine. This medication functions by inhibiting histamine, a substance that triggers the symptoms of allergic conjunctivitis, such as redness, itching, and tearing.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Vibolop 0.1% Eye Drops during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Use of Vibolop 0.1% Eye Drops while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Following application of Vibolop 0.1% Eye Drops, temporary blurred vision may occur. Refrain from driving until your vision is restored.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Vibolop 0.1% Eye Drop :
Should you forget a dose of Vibolop 0.1% Eye Drops, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vibolop 0.1% Eye Drop
| Label | Value |
|---|---|
| Chemical Category | Dibenzoxepine-based compound |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
